STAT3 is required for the gp130-mediated full activation of the c-myc gene

Journal of Experimental Medicine

Volumn 189, Issue 1, 1999, Pages 63-73

  Kiuchi, Nobuo ^a   Nakajima, Koichi ^a,b   Ichiba, Makoto ^a   Fukada, Toshiyuki ^a   Narimatsu, Masahiro ^a   Mizuno, Katsunori ^a   Hibi, Masahiko ^a   Hirano, Toshio ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

c myc; gp130; Interleukin 6; Promoter; Signal transducer and activator of transcription 3

Indexed keywords

CYTOKINE; GLYCOPROTEIN GP 130; GROWTH FACTOR; INTERLEUKIN 6 RECEPTOR; PROTEIN TYROSINE KINASE; RNA; STAT3 PROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; ELECTROPHORETIC MOBILITY; GENE ACTIVATION; GENETIC TRANSCRIPTION; IMMUNOBLOTTING; MOUSE; NONHUMAN; NORTHERN BLOTTING; ONCOGENE C MYC; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BINDING; SITE DIRECTED MUTAGENESIS;

ANIMALS; ANTIGENS, CD; B-LYMPHOCYTES; BINDING SITES; CARRIER PROTEINS; CELL CYCLE PROTEINS; CYTOKINE RECEPTOR GP130; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GENES, MYC; GENES, REPORTER; MEMBRANE GLYCOPROTEINS; MICE; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR; RECEPTORS, INTERLEUKIN-6; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 0033521595     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.1.63     Document Type: Article

References (87)

1. Darnell, J.J., I.M. Kerr, and G.R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 264:1415-1421.
2. Hou, X.S., and N. Perrimon. 1997. The JAK-STAT pathway in Drosophila. Trends Genet. 13:105-110.
3. Kawata, T., A. Shevchenko, M. Fukuzawa, K.A. Jermyn, N.F. Totty, N.V. Zhukovskaya, A.E. Sterling, M. Mann, and J.G. Williams. 1997. SH2 signaling in a lower eukaryote: a STAT protein that regulates stalk cell differentiation in dictyostelium. Cell. 89:909-916.
4. Yan, R., S. Small, C. Desplan, C.R. Dearolf, and J.E. Darnell, Jr. 1996. Identification of a Stat gene that functions in Drosophila development. Cell. 84:421-430.
5. Darnell, J.E., Jr. 1997. STATs and gene regulation. Science. 277:1630-1635.
6. Hirano, T., K. Nakajima, and M. Hibi. 1997. Signaling mechanisms through gp130: a model of the cytokine system. Cytokine Growth Factor Rev. 8:241-252.
7. Ihle, J.N., T. Nosaka, W. Thierfelder, F.W. Quelle, and K. Shimoda. 1997. Jaks and Stats in cytokine signaling. Stem Cells. 15:105-111.
8. O'Shea, J.J. 1997. Jaks, STATs, cytokine signal transduction, and immunoregulation: are we there yet? Immunity. 7:1-11.
9. Taniguchi, T. 1995. Cytokine signaling through nonreceptor protein tyrosine kinases. Science. 268:251-255.
10. David, M., L. Wong, R. Flavell, S.A. Thompson, A. Wells, A.C. Larner, and G.R. Johnson. 1996. STAT activation by epidermal growth factor (EGF) and amphiregulin. Requirement for the EGF receptor kinase but not for tyrosine phosphorylation sites or JAK1. J. Biol. Chem. 271:9185-9188.
11. Park, O.K., T.S. Schaefer, and D. Nathans. 1996. In vitro activation of Stat3 by epidermal growth factor receptor kinase. Proc. Natl. Acad. Sci. USA. 93:13704-13718.
12. Quelle, F.W., W. Thierfelder, B.A. Witthuhn, B. Tang, S. Cohen, and J.N. Ihle. 1995. Phosphorylation and activation of the DNA binding activity of purified Stat1 by the Janus protein-tyrosine kinases and the epidermal growth factor receptor. J. Biol. Chem. 270:20775-20780.
13. Vignais, M.L., H.B. Sadowski, D. Watling, N.C. Rogers, and M. Gilman. 1996. Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins. Mol. Cell. Biol. 16:1759-1769.
14. Cao, X., A. Tay, G.R. Guy, and Y.H. Tan. 1996. Activation and association of Stat3 with Src in v-Src-transformed cell lines. Mol. Cell. Biol. 16:1595-1603.
15. Danial, N.N., A. Pernis, and P.B. Rothman. 1995. Jak-STAT signaling induced by the v-abl oncogene. Science. 269: 1875-1877.
16. Yu, C.L., D.J. Meyer, G.S. Campbell, A.C. Larner, C. Carter-Su, J. Schwartz, and R. Jove. 1995. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science. 269:81-83.
17. Friedmann, M.C., T.S. Migone, S.M. Russell, and W.J. Leonard. 1996. Different interleukin 2 receptor beta-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation. Proc. Natl. Acad. Sci. USA. 93:2077-2082.
18. Mui, A.L., H. Wakao, T. Kinoshita, T. Kitamura, and A. Miyajima. 1996. Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: role of Stat5 in proliferation. EMBO (Eur. Mol. Biol. Organ.) J. 15:2425-2433.
19. Yamanaka, Y., K. Nakajima, T. Fukada, M. Hibi, and T. Hirano. 1996. Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation. EMBO (Eur. Mol. Biol. Organ.) J. 15:1557-1565.
20. Nakajima, K., Y. Yamanaka, K. Nakae, H. Kojima, M. Ichiba, N. Kiuchi, T. Kitaoka, T. Fukada, M. Hibi, and T. Hirano. 1996. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in Ml leukemia cells. EMBO (Eur. Mol. Biol. Organ.) J. 15:3651-3658.
21. Fukada, T., M. Hibi, Y. Yamanaka, M. Takahashi-Tezuka, Y. Fujitani, T. Yamaguchi, K. Nakajima, and T. Hirano. 1996. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of Stat3 in antiapoptosis. Immunity. 5:449-460.
22. Kaplan, M.H., Y.L. Sun, T. Hoey, and M.J. Grusby. 1996. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature. 382:174-177.
23. Kaplan, M.H., U. Schindler, S.T. Smiley, and M.J. Grusby. 1996. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity. 4:313-319.
24. Shimoda, K., J. van Deursen, M.Y. Sangster, S.R. Sarawar, R.T. Carson, R.A. Tripp, C. Chu, F.W. Quelle, T. Nosaka, D.A. Vignali, et al. 1996. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature. 380:630-633.
25. Takeda, K., T. Tanaka, W. Shi, M. Matsumoto, M. Minami, S. Kashiwamura, K. Nakanishi, N. Yoshida, T. Kishimoto, and S. Akira. 1996. Essential role of Stat6 in IL-4 signalling. Nature. 380:627-630.
26. Thierfelder, W.E., J.M. van Deursen, K. Yamamoto, R.A. Tripp, S.R. Sarawar, R.T. Carson, M.Y. Sangster, D.A. Vignali, P.C. Doherty, G.C. Grosveld, and J.N. Ihle. 1996. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature. 382:171-174.
27. Takeda, K., K. Noguchi, W. Shi, T. Tanaka, M. Matsumoto, N. Yoshida, T. Kishimoto, and S. Akira. 1997. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. USA. 94:3801-3804.
28. Kaplan, M.H., C. Daniel, U. Schindler, and M.J. Grusby. 1998. Stat proteins control lymphocyte proliferation by regulating p27Kip 1 expression. Mol. Cell. Biol. 18:1996-2003.
29. Nakajima, H., X.W. Liu, A. Wynshaw-Boris, L.A. Rosenthal, K. Imada, D.S. Finbloom, L. Hennighausen, and W.J. Leonard. 1997. An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor alpha chain induction. Immunity. 7:691-701.
30. Zong, C., R. Van, A. August, J.E. Darnell, Jr., and H. Hanafusa. 1996. Unique signal transduction of Eyk: constitutive stimulation of the JAK-STAT pathway by an oncogenic receptor-type tyrosine kinase. EMBO (Eur. Mol. Biol. Organ.) J. 15:4515-4525.
31. Bromberg, J.F., C.M. Horvath, D. Besser, W.W. Lathem, and J.E. Darnell, Jr. 1998. Stat3 activation is required for cellular transformation by v-src. Mol. Cell. Biol. 18:2553-2558.
32. Turkson, J., T. Bowman, R. Garcia, E. Caldenhoven, R.P. De Groot, and R. Jove. 1998. Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol. Cell. Biol. 18:2545-2552.
33. Chin, Y.E., M. Kitagawa, W.C. Su, Z.H. You, Y. Iwamoto, and X.Y. Fu. 1996. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science. 272:719-722.
34. Henriksson, M., and B. Luscher. 1996. Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res. 68:109-182.
35. Galaktionov, K., X. Chen, and D. Beach. 1996. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature. 382:511-517.
36. Kelly, K., B.H. Cochran, C.D. Stiles, and P. Leder. 1983. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell. 35:603-610.
37. Greenberg, M.E., A.L. Hermanowski, and E.B. Ziff. 1986. Effect of protein synthesis inhibitors on growth factor activation of c-fos, c-myc, and actin gene transcription. Mol. Cell. Biol. 6:1050-1057.
38. Roussel, M.F., J.L. Cleveland, S.A. Shurtleff, and C.J. Sherr. 1991. Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling. Nature. 353:361-363.
39. Conscience, J.F., B. Verrier, and G. Martin. 1986. Interleukin-3-dependent expression of the c-myc and c-fos proto-oncogenes in hemopoietic cell lines. EMBO (Eur. Mol. Biol. Organ.) J. 5:317-323.
40. Harel-Bellan, A., and W.L. Farrar. 1987. Modulation of proto-oncogene expression by colony stimulating factors. Biochem. Biophys. Res. Commun. 148:1001-1008.
41. Kessler, D.J., M.P. Duyao, D.B. Spicer, and G.E. Sonenshein. 1992. NF-kappa B-like factors mediate interleukin 1 induction of c-myc gene transcription in fibroblasts. J. Exp. Med. 176:787-792.
42. Klemsz, M.J., L.B. Justement, E. Palmer, and J.C. Cambier. 1989. Induction of c-fos and c-myc expression during B cell activation by IL-4 and immunoglobulin binding ligands. J. Immunol. 143:1032-1039.
43. Morrow, M.A., G. Lee, S. Gillis, G.D. Yancopoulos, and F.W. Alt. 1992. Interleukin-7 induces N-myc and c-myc expression in normal precursor B lymphocytes. Genes Dev. 6:61-70.
44. Nabata, T., S. Morimoto, E. Koh, T. Shiraishi, and T. Ogihara. 1990. Interleukin-6 stimulates c-myc expression and proliferation of cultured vascular smooth muscle cells. Biochem. Int. 20:445-453.
45. Reed, J.C., D.E. Sabath, R.G. Hoover, and M.B. Prystowsky. 1985. Recombinant interleukin 2 regulates levels of c-myc mRNA in a cloned murine T lymphocyte. Mol. Cell. Biol. 5:3361-3368.
46. Barone, M.V., and S.A. Courtneidge. 1995. Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src. Nature. 378:509-512.
47. Minami, Y., Y. Nakagawa, A. Kawahara, T. Miyazaki, K. Sada, H. Yamamura, and T. Taniguchi. 1995. Protein tyrosine kinase Syk is associated with and activated by the IL-2 receptor: possible link with the c-myc induction pathway. Immunity. 2:89-100.
48. Kawahara, A., Y. Minami, T. Miyazaki, J.N. Ihle, and T. Taniguchi. 1995. Critical role of the interleukin 2 (IL-2) receptor gamma-chain-associated Jak3 in the IL-2-induced c-fos and c-myc, but not bcl-2, gene induction. Proc. Natl. Acad. Sci. USA. 92:8724-8728.
49. Sakamaki, K., I. Miyajima, T. Kitamura, and A. Miyajima. 1992. Critical cytoplasmic domains of the common beta subunit of the human GM-CSF, IL-3, and IL-5 receptors for growth signal transduction and tyrosine phosphorylation. EMBO (Eur. Mol. Biol. Organ.) J. 11:3541-3549.
50. Watanabe, S., T. Itoh, and K. Arai. 1996. JAK2 is essential for activation of c-fos and c-myc promoters and cell proliferation through the human granulocyte-macrophage colony-stimulating factor receptor in BA/F3 cells. J. Biol. Chem. 271: 12681-12686.
51. Cleveland, J.L., M. Dean, N. Rosenberg, J.Y. Wang, and U.R. Rapp. 1989. Tyrosine kinase oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signaling pathways involving c-myc. conditional regulation of c-myc transcription by temperature-sensitive v-abl. Mol. Cell. Biol. 9:5685-5695.
52. Kuchino, Y., K. Nemoto, S. Kawai, and S. Nishimura. 1985. Activation of c-myc gene transcription by Rous sarcoma virus infection. Jpn. J. Cancer Res. 76:75-78.
53. Sovova, V., R. Friis, H. Fidlerova, and I. Hlozanek. 1993. c-myc gene activation as a permanent trait of RSV-infected quail cells. Int. J. Cancer. 53:983-987.
54. Stewart, M.J., S. Litz-Jackson, G.S. Burgess, E.A. Williamson, D.S. Leibowitz, and H.S. Boswell. 1995. Role for E2F1 in p210 BCR-ABL downstream regulation of c-myc transcription initiation. Studies in murine myeloid cells. Leukemia. 9:1499-1507.
55. Takeshita, T., T. Arita, M. Higuchi, H. Asao, K. Endo, H. Kuroda, N. Tanaka, K. Murata, N. Ishii, and K. Sugamura. 1997. STAM, signal transducing adaptor molecule, is associated with Janus kinases and involved in signaling for cell growth and c-myc induction. Immunity. 6:449-457.
56. Mudryj, M., S.W. Hiebert, and J.R. Nevins. 1990. A role for the adenovirus inducible E2F transcription factor in a proliferation dependent signal transduction pathway. EMBO (Eur. Mol. Biol. Organ.) J. 9:2179-2184.
57. Birchenall-Roberts, M.C., Y.D. Yoo, D.C. Bertolette III, K.H. Lee, J.M. Turley, O.S. Bang, F.W. Ruscetti, and S.J. Kim. 1997. The p120-v-Abl protein interacts with E2F-1 and regulates E2F-1 transcriptional activity. J. Biol. Chem. 272:8905-8911.
58. Wong, K.K., X. Zou, K.T. Merrell, A.J. Patel, K.B. Marcu, S. Chellappan, and K. Calame. 1995. v-Abl activates c-myc transcription through the E2F site. Mol. Cell. Biol. 15:6535-6544.
59. Zou, X., S. Rudchenko, K. Wong, and K. Calame. 1997. Induction of c-myc transcription by the v-Abl tyrosine kinase requires Ras, Raf1, and cyclin-dependent kinases. Genes Dev. 11:654-662.
60. Ahmed, N.N., H.L. Grimes, A. Bellacosa, T.O. Chan, and P.N. Tsichlis. 1997. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc. Natl. Acad. Sci. USA. 94:3627-3632.
61. Brennan, P., J.W. Babbage, B.M. Burgering, B. Groner, K. Reif, and D.A. Cantrell. 1997. Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. Immunity. 7:679-689.
62. Hirano, T. 1998. Interleukin 6 and its receptor: ten years later. Int. Rev. Immunol. 16:249-284.
63. Kawano, M., T. Hirano, T. Matsuda, T. Taga, Y. Horii, K. Iwato, H. Asaoku, B. Tang, O. Tanabe, H. Tanaka, et al. 1988. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature. 332:83-85.
64. Zhang, X.G., J.J. Gu, Z.Y. Lu, K. Yasukawa, G.D. Yancopoulos, K. Turner, M. Shoyab, T. Taga, T. Kishimoto, R. Bataille, and B. Klein. 1994. Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130. J. Exp. Med. 179:1337-1342.
65. Cressman, D.E., L.E. Greenbaum, R.A. DeAngelis, G. Ciliberto, E.E. Furth, V. Poli, and R. Taub. 1996. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science. 274:1379-1383.
66. Nakajima, K., T. Kusafuka, T. Takeda, Y. Fujitani, K. Nakae, and T. Hirano. 1993. Identification of a novel interleukin-6 response element containing an Ets-binding site and a CRE-like site in the junB promoter. Mol. Cell. Biol. 13: 3027-3041.
67. Nakae, K., K. Nakajima, J. Inazawa, T. Kitaoka, and T. Hirano. 1995. ERM, a PEA3 subfamily of Ets transcription factors, can cooperate with c-Jun. J. Biol. Chem. 270:23795-23800.
68. Kovesdi, I., R. Reichel, and J.R. Nevins. 1986. Identification of a cellular transcription factor involved in E1A transactivation. Cell. 45:219-228.
69. Ichiba, M., K. Nakajima, Y. Yamanaka, N. Kiuchi, and T. Hirano. 1998. Autoregulation of the Stat3 gene through cooperation with a cAMP-responsive element-binding protein. J. Biol. Chem. 273:6132-6138.
70. Kojima, H., K. Nakajima, and T. Hirano. 1996. IL-6-inducible complexes on an IL-6 response element of the junB promoter contain Stat3 and 36 kDa CRE-like site binding protein(s). Oncogene. 12:547-554.
71. Chaturvedi, P., S. Sharma, and E.P. Reddy. 1997. Abrogation of interleukin-3 dependence of myeloid cells by the v-src oncogene requires SH2 and SH3 domains which specify activation of STATs. Mol. Cell. Biol. 17:3295-3304.
72. Stahl, N., T.J. Farruggella, T.G. Boulton, Z. Zhong, J.J. Darnell, and G.D. Yancopoulos. 1995. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science. 267:1349-1353.
73. Nakajima, K., and R. Wall. 1991. Interleukin-6 signals activating junB and TIS11 gene transcription in a B-cell hybridoma. Mol. Cell. Biol. 11:1409-1418.
74. Kim, H., T.S. Hawley, R.G. Hawley, and H. Baumann. 1998. Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells. Mol. Cell. Biol. 18:1525-1533.
75. Hiebert, S.W., M. Lipp, and J.R. Nevins. 1989. E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor. Proc. Natl. Acad. Sci. USA. 86:3594-3598.
76. Decker, T., P. Kovarik, and A. Meinke. 1997. GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. J. Interferon Cytokine Res. 17:121-134.
77. Horvath, C.M., Z. Wen, and J.E. Darnell, Jr. 1995. A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev. 9:984-994.
78. Seidel, H.M., L.H. Milocco, P. Lamb, J.E. Darnell, Jr., R.B. Stein, and J. Rosen. 1995. Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc. Natl. Acad. Sci. USA. 92:3041-3045.
79. Shimizu, S., T. Hirano, R. Yoshioka, S. Sugai, T. Matsuda, T. Taga, T. Kishimoto, and S. Konda. 1988. Interleukin-6 (B-cell stimulatory factor 2)-dependent growth of a Lennert's lymphoma-derived T-cell line (KT-3). Blood. 72: 1826-1828.
80. Chellappan, S.P., S. Hiebert, M. Mudryj, J.M. Horowitz, and J.R. Nevins. 1991. The E2F transcription factor is a cellular target for the RB protein. Cell. 65:1053-1061.
81. Nevins, J.R., S.P. Chellappan, M. Mudryj, S. Hiebert, S. Devoto, J. Horowitz, T. Hunter, and J. Pines. 1991. E2F transcription factor is a target for the RB protein and the cyclin A protein. Cold Spring Harbor Symp. Quant. Biol. 56: 157-162.
82. Weintraub, S.J., C.A. Prater, and D.C. Dean. 1992. Retinoblastoma protein switches the E2F site from positive to negative element. Nature. 358:259-261.
83. Weintraub, S.J., K.N. Chow, R.X. Luo, S.H. Zhang, S. He, and D.C. Dean. 1995. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature. 375:812-815.
84. Ihle, J.N. 1995. The Janus protein tyrosine kinase family and its role in cytokine signaling. Adv. Immunol. 60:1-35.
85. Ihle, J.N., and I.M. Kerr. 1995. Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet. 11:69-74.
86. Azam, M., C. Lee, I. Strehlow, and C. Schindler. 1997. Functionally distinct isoforms of STAT5 are generated by protein processing. Immunity. 6:691-701.
87. Wang, D., D. Stravopodis, S. Teglund, J. Kitazawa, and J.N. Ihle. 1996. Naturally occurring dominant negative variants of Stat5. Mol. Cell. Biol. 16:6141-6148.